Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00072475
Status:
COMPLETED
Last Update Posted:
2016-08-01
First Post:
2003-11-04
Brief Title:
Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes
Sponsor:
Alliance for Clinical Trials in Oncology
Organization:
Alliance for Clinical Trials in Oncology
Conditions & Keywords Data
Conditions:
| Name |
|---|
| MyelodysplasticMyeloproliferative Neoplasms |
| Leukemia |
| Myelodysplastic Syndromes |
Keywords:
| Name | View |
|---|---|
| refractory anemia with excess blasts | View |
| refractory anemia with ringed sideroblasts | View |
| refractory cytopenia with multilineage dysplasia | View |
| chronic myelomonocytic leukemia | View |
| de novo myelodysplastic syndromes | View |
| secondary myelodysplastic syndromes | View |
| myelodysplasticmyeloproliferative neoplasm unclassifiable | View |
| refractory anemia | View |
| previously treated myelodysplastic syndromes | View |